glp-1 alzheimer's disease Coveted Drugs Show Early Promise in Neuroprotective Actions of Glucagon-Like Peptide-1
Description
National Taiwan University researchers highlight the benefits of GLP-1 receptor agonists (GLP-1 RAs) in reducing mortality and severe cardiovascular and renal outcomes for diabetic patients with acute kidney disease (AKD)
But there also have been troubling side effects reported.
The Lancet 2026
Bariatric surgeries such as Roux-en-Y ...
Trulicity offers a simple, once-weekly way to control type 2 diabetes and prevent cardiovascular disease (CVD) or help with existing CVD
Understanding this connection helps explain why these medications support metabolic health beyond weight loss alone
